Work

Tofacitinib (CP-690,550), a Janus Kinase Inhibitor for Dry Eye Disease

Year: 2012

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Ophthalmology

DOI: 10.1016/j.ophtha.2012.01.028

Authors: Shiao Hui (Melissa) Liew, Kelly K. Nichols, Karen J. Klamerus, Jim Z. Li, Min Zhang, Gary N. Foulks

Institutions: Pfizer (United States), University of Houston, University of Louisville

Language: English

Topic: Ocular Surface and Contact Lens

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Pfizer, Allergan

OpenAlex ID: W2167265097

FWCI: 7.428

Cites: 22

Cited by: 94

Related to: 10